Effectiveness of interventions by the Threat Management Team of the Netherlands Police Agency: A retrospective study.

Author(s):  
Bram B. Sizoo ◽  
Dorien van Nobelen
1999 ◽  
Vol 45 (8) ◽  
pp. 1013-1022 ◽  
Author(s):  
Peter Paul A Mersch ◽  
Hermine M Middendorp ◽  
Antoinette L Bouhuys ◽  
Domien G.M Beersma ◽  
Rutger H van den Hoofdakker

2021 ◽  
pp. bjophthalmol-2020-316234
Author(s):  
Jan Roelof Polling ◽  
Caroline Klaver ◽  
Jan Willem Tideman

PurposeData on myopia progression during its entire course are scarce. The aim of this study is to investigate myopia progression in Europeans as a function of age and degree of myopia from first prescription to final refractive error.MethodsThe Drentse Refractive Error and Myopia Study assessed data from a branch of opticians in the Netherlands from 1985 onwards in a retrospective study. First pair of glasses prescribed was defined as a spherical equivalent of refraction (SER) ≤−0.5 D to ≥−3.0 D. Subjects with prescriptions at an interval of at least 1 year were included in the analysis.ResultsA total of 2555 persons (57.3% female) met the inclusion criteria. Those with first prescription before the age of 10 years showed the strongest progression (−0.50 D; IQR: −0.75 to −0.19) and a significantly (p<0.001) more negative median final SER (−4.48 D; IQR: −5.37 to −3.42). All children who developed SER ≤−3 D at 10 years were highly myopic (SER ≤−6D) as adults, children who had SER between −1.5 D and −3 D at 10 years had 46.0% risk of high myopia, and children with SER between −0.5 D and −1.5 D had 32.6% risk of high myopia. Myopia progression diminished with age; all refractive categories stabilised after age 15 years except for SER ≤−5 D who progressed up to −0.25 D annually until age 21 years.ConclusionOur trajectories of the natural course of myopia progression may serve as a guide for myopia management in European children. SER at 10 years is an important prognostic indicator and will help determine treatment intensity.


2015 ◽  
Vol 148 (4) ◽  
pp. S-378 ◽  
Author(s):  
Shannon L. Kanis ◽  
Alison de Lima ◽  
Zuzana Zelinkova ◽  
Gerard Dijkstra ◽  
Rachel West ◽  
...  

2011 ◽  
Vol 49 (5) ◽  
pp. 600-604
Author(s):  
Esther Vis ◽  
Herbert van den Berge

We questioned how many patients with epistaxis can be treated by cautery without the use of nasal packing, as cautery is more effective and efficient. To investigate this, we performed a retrospective study of a cohort of 418 patients with epistaxis who presented to one ENT consultant at the ENT department of Medisch Centrum Leeuwarden (the Netherlands) between 1997 and 2007. Main outcomes were the treatment modality (cautery and/or nasal packing), recurrence of epistaxis and need for hospitalization. In 98% of all patients the bleeding site could be found and treated by cautery. The incidence of recurrent bleeding was 6%. Two percent of all patients had to be admitted to the hospital. This is considerably lower compared with recurrence rates and hospitalization after treatment by nasal packing known from the literature. Therefore we concluded that nearly all patients can be effectively treated by cautery with a low recurrence rate. In addition, this method of treatment is very cost effective. Because cautery requires skill and appropriate facilities, we recommend special attention for this in ENT training programs.


2020 ◽  
Vol 14 ◽  
pp. 175346662090527 ◽  
Author(s):  
Anne M. Akkerman-Nijland ◽  
Mina Yousofi ◽  
Bart L. Rottier ◽  
Hester Van der Vaart ◽  
Johannes G. M. Burgerhof ◽  
...  

Background: Pseudomonas aeruginosa ( Pa) is the predominant pulmonary pathogen in patients with cystic fibrosis (CF). Tobramycin nebulization is used for the eradication of Pa infection. Nowadays, tobramycin dry powder inhalation (DPI) is available as well. This study reports the results of eradicating Pa with tobramycin DPI versus nebulization. Methods: Adult CF patients with a Pa isolation between September 2010 and September 2017 from the University Medical Centre Groningen (UMCG), the Netherlands, were included in this retrospective study. Results: In total 27 Pa isolations were recorded. In 13 of these, eradication was attempted with tobramycin, 7 with DPI and 6 with nebulization. DPI eradicated Pa successfully in six isolations (85.7%). Of these, one patient received additional oral ciprofloxacin and one received intravenous ceftazidime. Nebulization eradicated three Pa isolations (50.0%), in two of these, additional oral ciprofloxacin was given. Conclusion: Eradication rates of DPI tobramycin are comparable with those for nebulized tobramycin reported in the literature. This study suggests that DPI tobramycin is an alternative to nebulized tobramycin for eradication of Pa. Trial registration: The Medical Ethics Committee of the UMCG granted a waiver (METC2017-349), as they concluded that this study was not subject to the Medical Research Involving Human Subjects Act. The reviews of this paper are available via the supplemental material section.


2020 ◽  
Vol 51 (3) ◽  
Author(s):  
Anna Salazar-Casals ◽  
Klaas Marck ◽  
Tijmen de Jong ◽  
James Collins ◽  
Joost Dorgelo ◽  
...  

2011 ◽  
Vol 42 (4) ◽  
pp. 565-577 ◽  
Author(s):  
Koen Meeussen ◽  
Lieve Van den Block ◽  
Michael Echteld ◽  
Nathalie Bossuyt ◽  
Johan Bilsen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document